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The Health Information Technology for Clinical and Economic Health (HITECH) Act of 2009 
encouraged the meaningful use of the electronic health record (EHR) by health care providers in the 
United States. “Meaningful use” monetary incentives were offered by the Center for Medicare and 
Medicaid Services (CMS) for health care providers who met standards of documenting in and using the 
EHR. While clinical pharmacists typically work in clinics and hospitals in the United States, they were not 
considered eligible professionals who could receive incentives for using the EHR. There is a great deal of 
literature regarding the use of the EHR by eligible professionals, but not by ineligible professionals like 
clinical pharmacists. One way that clinical pharmacists assist in meaningful use criteria is by developing 
computerized provider order entries (CPOEs). The purpose of this study is to assess the perception and 

















In response to proof that paper-based records would increase health care costs, fragment care, 
and cause medical decisions to be made without complete data, Congress signed the Health Information 
Technology for Economic and Clinical Health (HITECH) Act into law on February 17, 2009. HITECH was 
part of the American Recovery and Reinvestment Act and had a goal of increasing the adoption of the 
electronic health record (EHR). In fact, HITECH mandated the adoption of the EHR and incentivized 
health care providers to promote the “meaningful use” of it (HITECH, 2009). This meant that not only did 
health care providers need to learn about and begin documenting patient information into the EHR, but 
they also needed to use it in a way that would benefit the US health care system to ensure patients 
received quality, timely, and affordable health care. Prior to the HITECH Act, many health care providers 
were primarily using paper-based forms of health information documentation (Anderegg & Gumpper, 
2012). With the adoption of meaningfully using the EHR, it offered providers a way to optimize quality-
based care. It also allowed an interdisciplinary approach to care because the EHR would allow viewing 
from multiple providers at the same time. This opened the door for pharmacists, specifically clinical 
pharmacists, to have a greater impact on patient care.  
       The payment incentives for meeting the meaningful use criteria were provided yearly, beginning in 
2011, by the Center for Medicare and Medicaid Services (CMS) to “eligible professionals” and “eligible 
hospitals.” Table 1 displays the eligible professionals and hospitals that could receive the incentive 
payments. Each eligible category has its own stipulations in regard to practice setting, and whether it’s 
part of Medicare, Medicaid, or both. Pharmacists were not classified as eligible professionals, while 
physicians, nurse practitioners, dentists, etc. were. Because of this, to assist in meeting criteria for 
meaningful use, clinical pharmacists were the type of pharmacists that would greatly be able to assist in 
obtaining meaningful use criteria because they can practice in eligible hospitals.  The American College 
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of Clinical Pharmacy (ACCP) defines a clinical pharmacist as a pharmacist that “works directly with 
physicians or other health professionals and patients to ensure that the medications prescribed for 
patients contribute to the best possible outcomes,” (ACCP, 2020). Clinical pharmacists practice in acute 
care hospitals, ambulatory care clinics, and diabetes and anticoagulation clinics to help manage patients’ 
medication interactions, dosing, duration, etc. Clinical pharmacists are part of the interdisciplinary team 
to help manage patient care in each of those settings. 
Table 1. Eligible Professionals and Hospitals for CMS Meaningful Use Incentive Payments 
 
Mennemeyer et al. (2017) explained, “By the end of 2014, the federal government had 
distributed $28.1 billion to eligible physicians and other professionals through the Medicare and 
Medicaid EHR MU programs,” (p.375). The meaningful use criteria were categorized into three stages. 
Stage 1 criteria were released in 2011 and focused on setting the foundational goals for using the EHR. 
Stage 1 included objectives such as: maintaining a problem list and active medication and allergy list, 
recording patient demographics, smoking status, clinical summary education, and medication 
reconciliation. Stage 2 criteria were released in 2014 and advanced clinical processes which included: 
Eligible Hospitals Medicare Incentive Program Medicaid Incentive Program 
Acute Care Hospitals ü ü 
Critical Access Hospitals ü ü 
Indian Health Service Hospitals ü ü 
Children’s Hospitals  ü 
Cancer Hospitals  ü 
Territory Hospitals  ü 
Eligible Professionals Medicare Incentive Program Medicaid Incentive Program 
Physicians (MD/DO) ü ü 
Podiatrists (DPM) ü  
Optometrists (OD) ü ü 
Chiropractors (DC) ü  
Nurse Practitioners  ü 
Dentists/Oral Surgeons (DDS/DMD) ü ü 
Physician Assistants (PA-C)  ü 
Certified Nurse Midwives (CNM)  ü 
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inputting vital signs, providing timely access to patient health information, transmitting patients’ health 
information to a third party, providing reminders for follow-up and educational resources, and recording 
family history, etc., (Alfayez, 2018). Stage 3, the most recently released stage, contained measures that 
aimed to promote HER interoperability. Protecting electronic protected health information, generating 
electronic prescriptions, using computerized provider order entry (CPOE) for medication or laboratory 
orders, and implementing clinical decision support systems (CDSs) were some of the objectives outlined 
in the stage 3 (CMS, 2018). For eligible hospitals, there were 6 objectives that that needed to be met. In 
November of 2016, CMS released a final rule that modified criteria due to response of stakeholder 
feedback. 
While clinical pharmacists were not “eligible professionals” who received monetary incentives 
from the Centers for Medicare and Medicaid Services (CMS) for meaningful use, the profession had to 
adapt to using the EHR in eligible hospitals, whether that be by documenting care objectives into patient 
notes or creating medication-based templates for computerized provider order entry (CPOE).  CPOE 
“refers to the process of providers entering and sending treatment instructions – including medication, 
laboratory, and radiology orders – via computer application (ONC, 2018). With pharmacists’ extensive 
knowledge regarding drug dosing, interactions, adverse reactions, and effectiveness, they are important 
professionals when it comes to optimizing medication orders in hopsitals. In fact, one of the clinical 
pharmacy roles that evolved because of HITECH and CMS Meaningful Use was helping to create 
medication CPOE templates to improve patient care.  Prgomet et al. (2017) completed a meta-analysis 
looking at the effect of CPOE and CDSs on medication errors, length of stay, and mortality in intensive 
care units. Their analysis results showed that when compared to paper-based ordering, “CPOE systems 
in intensive care units were associated with 85% reduction in medication prescribing error rates and 




Ascension Saint Thomas Rutherford Hospital (ASTR), which qualifies as an acute care hospital in 
Murfreesboro, TN, has a committee made up of physicians, pharmacists, nurses, and other key 
stakeholders that work together to create CPOEs called Powerplans. Clinical pharmacists play a major 
role in helping to format the medication CPOE templates. The medication CPOE templates are created 
for a number of reasons.  
 The Purpose and Significance of the Study 
While there are a great deal of scholarly articles that have been published regarding the use and 
the adoption of the EHR by eligible professionals, there is a lack of data regarding its use by ineligible 
professionals. Pharmacists, and specifically clinical pharmacists in eligible hospitals, have been 
incorporated into the interdisciplinary team and are a valued healthcare professional in the hospital 
setting. The purpose of this study is to understand the impact that pharmacists believe medication 
CPOEs have had on patient outcomes (reduced medication errors (ADEs), adverse drug reactions, length 
of stay, mortality, correct dosing of drugs, antimicrobial stewardship, drug interactions) at ASTR and to 
describe the new role that clinical pharmacists have to develop these CPOEs because of HITECH and 













 The literature articles addressed the adoption of HITECH and meaningful use by hospitals and 
health care providers. The articles were found by searching PubMed. 2010 was the earliest year that 
articles were shown. The search terms included: HITECH, HITECH Act, pharmacy, meaningful use, EHR, 
and CPOE. Key concepts from one article provided information relevant for an overview of HITECH and 
the future of it. The article by Washington, DeSalvo, and Mostashari discussed the adoption of EHR as 
reported by physicians at their practice sites. The article explains that “Today, almost all U.S. hospitals 
and nearly 80% of office-based practices use certified EHRs” (2017). They provided a graph (see Figure 1) 
that displays a timeline of adoption of “any”, “basic”, and “certified” EHR in both office-based and acute 
care hospital settings.  
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                                           Figure 1 (Washington et al.) 
Any EHR means that physicians have reported that their location used an electronic health record. Basic 
EHR means the location documented every computerized function (patient demographics, imaging 
results, patient medications, allergies, etc.) into the EHR. Certified EHR indicates that a physician 
reported that their location’s EHR met the criteria for meaningful use. This is important to note because 
while hospitals had “Basic EHR” reported in 2008, they did not meet meaningful use criteria until 2011. 
A similar timeline is reported in office-based practices as well.  
 “Health care providers, especially physicians, have borne the brunt of this transformation,” 
(Washington et al., 2017). This article primarily surveyed physicians, it did not survey pharmacists. 
Another article in this literature review discusses the major issues that pharmacists have had when 
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documenting into the EHR. Other concepts in this article are important to include in this literature 
review like the fact that regulation is still an obstacle with health information technology and the 
limitations with billing and compliance needs.  
Populations Studied 
 The second article goes into more detail and discusses pharmacists and their role in  
documenting meaningful use objectives into the EHR, specifically stages 1 and 2. Alfayez et al. states,  
“Stage 1 concentrates on capturing and sharing data, Stage 2 on advanced care processes and 
integration into patient care, and Stage 3 on improving patient outcomes,” (2018). One of the main 
points of the article is that pharmacists are not considered “eligible professionals” that can receive 
payment incentives for reaching objectives. This article studies El Rio Community Health Center which is 
health care system that provides care to medically underserved in Arizona.  For approximately six 
inconsecutive months, clinical pharmacists’ and other health care providers’ documentation was tracked 
using their health information system. The specific patient population that was studied was patients 
with diabetes mellitus.  
Study Method 
 The literature review had several different types of surveying done in each article. The first 
articlce by Washington et al. used surveying of physicians to report their adoption level of EHR (2017). 
The second article by Alfayez et al. was a “retrospective observational study of randomly selected 
patients with type 2 diabetes,” (2018). Approximately 800 encounters were tracked for MU objectives 
using the NextGen EHR. The final study looked at pharmacists’ role in documentation and medication 
reconciliation in a the EHR.  
Findings 
 From reviewing the literature, HITECH of 2009 has achieved its intended purpose to expand the 
adoption of EHR and expand the economy in the US. In 2017, Washington et al. stated that “almost all 
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US hospitals and nearly 80% of office-based practices use certified EHRs (2017). “Certified EHR” meant 
that not only had the practice site used an EHR, but it also used it in a way that met criteria of 
meaningful use. The payment incentives for meeting meaningful use criteria were provided yearly by 
the Center for Medicare and Medicaid Services and pharmacists were not classified as “eligible 
professionals” to receive the incentive payments. The meaningful use criteria were broken up into three 
stages. Stage 1 criteria included the following: maintaining a problem list, maintaining an active 
medication and allergy list, recording patient demographics, smoking status, clinical summary education, 
and medication reconciliation. Stage 2 criteria became more specific and included stage 1 criteria plus: 
vital signs, providing timely online access to health information, transmitting patients’ health 
information to a third party, providing reminders for follow-up and educational resources, and recording 
family history (Alfayez et al., 2017). Stage 3 objectives included: implementing clinical decision support 
interventions (CDS), using computerized provider order entry (CPOE), public health reporting, providing 
patients with timely electronic access to health information, and having protected health information, 
(CMS, 2020).  
The American College of Clinical Pharmacy defines a clinical pharmacist as a pharmacist that 
“works directly with physicians other health professionals, and patients to ensure that the medications 
prescribed for patients contribute to the best possible health outcomes.” Clinical pharmacists are 
located in acute care hospitals, ambulatory care clinics, and diabetes and anticoagulation clinics to help 
manage patients’ medication interactions, dosing, duration, etc. In the clinical setting, pharmacists use 
the EHR to document and update medication lists, complete medication reconciliations, patient 
evaluation and drug monitoring (Nelson et al., 2017). The expanded role of clinical pharmacists 
contributes to documenting in the EHR on a regular basis in many hospitals. And in the study by Alfayez 
et al., it was concluded that clinical pharmacists were “at least as effective as other health care providers 
in documenting meaningful use criteria, (2017). Pharmacists can also create templates for optimally 
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dosing medicine. This is called clinical decision support tools, and these tools ease the providers 
prescribing if they are created in a manner that is easy to read and follow. However clinical decision 
support by clinical pharmacists remains underutilized (Nelson et al.) Pharmacists are not “eligible 
professionals”, yet from the literature, they contribute to the EHR in numerous ways. As telehealth 
emerges as a way to provide care to patients without being in person with a provider, it is equally, if not 
more important, to use the EHR more efficiently and effectively with a pharmacist’s knowledge and 
support.  
Limitations 
Limitations to the Washington et al. are the persons reporting. The study surveyed only 
physicians and their attestations to using EHR. The study could be a better representation of use if it 
included reports from nurses, nurse practitioners, PAs, and other eligible professionals. Some of the 
limitations to the Alfayez et al. study are the locations. The study was completed in a health system for 
the underserved in Arizone. Also, the patient population was patients with type 2 diabetes mellitus.  To 
broaden the concept, it would be neat to see another health system and a different patient population 
for the encounters to occur. The study also solely focused on stage 1 and stage 2 of meaningful use, 
stage 3 documentation would broaden the scope of pharmacist documentation and provide a more 
recent study.  
Conclusions 
There are still many implications to improve the use of EHR in health systems as well as many 
regulatory challenges. Pharmacists play a role in updating medication lists in patient profiles, 
documenting patient allergies, providing CPOE, CDS, and in El Rio Community Health Center, 
pharmacists met some meaningful use objectives more than other providers. HITECH impacted health 
systems across the US and initiated the creation of health information system companies as well as 
provided a commonplace to document patient health information. The EHR allows information to be 
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used with an interdisciplinary approach and pharmacists have incorporated themselves into the process 


























 The purpose and primary endpoint of this study is to determine the perception and use of 
CPOEs by clinical pharmacist. Secondary endpoints include clinical pharmacists’ perspective of 
PowerPlans (their term for CPOEs within their health system) impact on medication safety, antimicrobial 
stewardship, and involvement in the creation of their PowerPlans.  
Research Questions 
How to clinical pharmacists describe their knowledge of CPOE and its use? Do pharmacists at 
Ascension Saint Thomas Rutherford Hospital believe that Powerplans help to prevent medication errors, 
morality, and length of stay? Do they recommend the use of PowerPlans in institutional and clinical 
settings throughout the United States? 
Methods 
Participants and Research Site 
 The participants of this survey included all pharmacists at Ascension Saint Thomas  
Rutherford (ASTR), Murfreesboro, TN, USA. ASTR is a 358-bed hospital and averages 12,000 admissions 
 and 90,000 emergency room visits annually. Services at ASTR include heart and vascular care, 
orthopedics, intensive care, and maternity services.  ASTR is member of Saint Thomas Health and is the 
leading health care provider in Rutherford County just outside of Nashville. Rutherford County has a 
population of nearly 288,906 in 2014, an increase of more than 50 percent since 2000 (Ascension, 2021).  
 There are approximately 30 clinical pharmacists on staff at ASTR. The pharmacy model at ASTR is 
decentralized, meaning the pharmacists are not working solely in the hospital pharmacy, but practicing 
in other areas throughout the hospital with the nurses and doctors to answer any drug-related 
questions and giving suggestions to optimize patient care. They work in many areas of the hospital 
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including: emergency department, critical care units, medical/surgery, and on the in-patient floors. 
Participants received informed consent. 
 The health information system used at ASTR is Cerner. Within Cerner, pharmacists, nurses, 
physicians, and other stakeholders create order sets, called PowerPlans within the Cerner EHR. These 
PowerPlans are a form of CPOE and allow for simultaneous ordering of all components associated with 
clinical care and drug monitoring. This includes lab tests, x-rays, and medications. One example of how a 
PowerPlan can be used is when a health care provider is attempting to order oral vancomycin to treat a 
Clostridioides difficile infection, the order will prompt the provider to discontinue all medications that 
have been shown to cause a Clostridioides difficile infection. Without that prompt, a provider may forget 
to discontinue those medications and the patient would remain on them while trying to treat the 
infection that they thought to be causing. Another type of CPOE that is created is one for a thrombolytic 
that is used to treat an ischemic stroke. Thrombolytics are very effective in dissolving the clot, but they 
have many contraindications to their use that includes a time limit for their use. Clinical pharmacists are 
aware of these contraindications, and therefore can greatly assist in the creation of the CPOE template 
for the thrombolytics. These CPOEs would help prevent the use of thrombolytics when they are 
contraindicated and therefore increase medication safety.  
Research Design and Data Collection  
In this single center, cross sectional study, practicing pharmacists at ASTR were emailed a link to a 
Google Forms survey. They had approximately 14 days to complete and submit the survey. The survey 
questions were multiple choice with one free text question. There were seventeen total questions, four 
of them were demographic-based questions to better gauge the pharmacy population, and thirteen of 
them were Likert scale to assess the information related to the purpose of the study. Written informed 
consent was given to each of the participants. IRB approval was not required. A copy of the questions in 
the survey are included below.  
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1. How do you describe your knowledge of computerized provider order entry (CPOE) and its use? 
• Extremely knowledgeable 
• Very knowledgeable 
• Moderately knowledgeable 
• Slightly knowledgeable 
• Not at all knowledgeable 
 
2. How effective are PowerPlans in reducing medication errors at ASTR? 
• Extremely effective 
• Very effective 
• Moderately effective 
• Slightly effective 
• Not at all effective  
 
3. How helpful are PowerPlans to improve clinical decisions at ASTR? 
• Extremely helpful 
• Very helpful 
• Moderately helpful 
• Slightly helpful 
• Not at all helpful 
 
4. To what extent do PowerPlans increase antimicrobial stewardship at ASTR? 
• Extremely high 
• Very high 
• Moderately high 
• Slightly high 
• Not at all  
 
5. To what extent do you think health care providers at ASTR prefer ordering medications with a 
PowerPlan versus without a PowerPlan? 
• Extremely high 
• Very high 
• Moderately high 
• Slightly high 
• Not at all  
 
6. To what extent do providers use PowerPlans when appropriate at ASTR? 
• Extremely high 
• Very high 
• Moderately high 
• Slightly high 
• Not at all 
 
7. How helpful are PowerPlans in reducing length of stay at ASTR?  
• Extremely helpful 
• Very helpful 
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• Moderately helpful 
• Slightly helpful 
• Not at all  
 
8. How helpful are PowerPlans in reducing mortality at ASTR? 
• Extremely helpful 
• Very helpful 
• Moderately helpful 
• Slightly helpful 
• Not at all  
 
9. At what degree do PowerPlans reduce pharmacy staff workload at ASTR? 
• Extremely high 
• Very high 
• Moderately high 
• Slightly high 
• Not at all  
 
10. Have you ever assisted in creating a PowerPlan? 
• Yes 
• No  
 
11. If you responded "yes" or "maybe" to the previous question (question 10), please describe the 
PowerPlan that you helped to create. If you answered "no", please put N/A and move to the 
next question. 
 
12. How likely would you work in a pharmacy setting that required creating and developing 
PowerPlans? 
• Very likely 
• Somewhat likely 
• Somewhat unlikely 
• Very unlikely 
• Unsure 
 
13. How likely would you be to recommend the use of PowerPlans in institutional and clinical 
settings throughout the United States? 
• Very likely 
• Somewhat likely 
• Somewhat unlikely 




1. What is your age in years? 
a. 20-25 
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b. 26-29 years 
c. 30-39 years 
d. 40-49 years 
e. 50+ years 
 
2. How many years have you worked as a pharmacist? 
a. 0-2 years 
b. 3-5 years 
c. 6-10 years 
d. 11-20 years 
e. 20+ years 
 
3. How long have you worked at Ascension Saint Thomas Rutherford? 
a. Less than 1 year 
b. 1-2 years 
c. 3-5 years 
d. Greater than 5 years 
 
4. What area of pharmacy do you practice? 
 
a. Central pharmacy 


















 The survey link allowed for responses for two weeks. There was a total of twenty-three 
pharmacists that responded to the survey. Each of them completed the entire survey. The summary of 
demographic findings was that the majority (56.5%) of the participants were 30-39 years of age. Eleven 
of the participants (47.8%) practiced in medical/surgery area of ASTR. Six (26.1%) of the participants 
practiced in the critical care area, and five (21.7%) practiced in “Other.” Other could include a range of 
areas such as administrative, staffing, etc. pharmacists. The majority (73.9%) of the participants have 
worked as pharmacist for ten or less years. Figure 2 displays a chart of the participant time worked as 
pharmacists. Finally, the majority (52.2%) of participants have worked specifically at ASTR for three years 








Time Worked as a Pharmacist 
(years)
0 to 10 10 plus
 20 
Perceptions of CPOEs 
 65.2% (15/23) of participants described their knowledge of CPOE and its use as extremely or 
very knowledgeable. The rest of the participants, 34.8% (8/23), described their knowledge of CPOE and 
its use as moderately knowledgeable. None of the participants described their knowledge of CPOE and 
its use as slightly knowledgeable or not at all.  
 82.6% (19/23) of the participants thought that PowerPlans were very or extremely helpful in 
improving clinical decisions at ASTR. After combining two questions, it was determined that 21.7% 
(10/46) participants thought that PowerPlans were very helpful at reducing patient mortality and length 
of stay at ASTR. Though 47.8% (22/46) of participants thought that PowerPlans were moderately helpful 
at reducing patient mortality at ASTR. 13% (3/23) thought that PowerPlans were not at all helpful at 
reducing patient length of stay at ASTR. 47.8% (11/23) participants thought that PowerPlans had a 
moderately high extent at increasing microbial stewardship at ASTR. 52.2% (12/23) of the participants 
have assisted in creating a PowerPlan. The descriptions of the PowerPlans that they have helped to 
create are included in Table 2.   
 
Table 2. Participant’s Description of PowerPlan They Helped to Create 
Participant Description of PowerPlan Created 
1 • Emergency department (ED) acute pain and stroke, misc.  
2 • Retinopathy of prematurity (ROP) in neonates, NICU IV fluid sub phase 
3 • Multimodal pain 
4 • Acute ischemic stroke, intracranial hemorrhage (ICH) 
5 • Insulin drip for hypertriglyceridemia 
6 • ED envenomation’s, addition of Anavip ® 
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7 • Tenecteplase and stroke 
8 • Existing NICU PowerPlans, antibiotic dosing and frequency 
9 • Infectious disease (ID) related such as pneumonia, daptomycin dosing, C. 
difficile 
10 • Various pediatrics 
11 • Tenecteplase for safety, and calcitonin for appropriateness 
12 • Sotalol inititiation 
 
 95.6% (22/23) of the participants were very or somewhat likely to recommend the use of 
PowerPlans in institutional and clinical settings throughout the United States. One participant (4.3%) 
was unsure if they would recommend the use of PowerPlans in institutional and clinical settings 
throughout the United States. None of the participants were unlikely to recommend the use of 
PowerPlans in institutional and clinical settings throughout the United States. Not all responses are 














Limitations of the Study 
 One limitation to this research was that it was a single-center study. If it was multi-center, it 
would have provided a greater number of participants as well as increase the external validity. The 
clinical pharmacists at ASTR are primarily located in the emergency department, critical care units, and 
medical/surgery inpatient floors. However, clinical pharmacists’ practice in a great deal more clinical 
settings in the US including ambulatory care, oncology, behavioral health, and pediatric areas. If this 
study was completed at a larger institution, it may have provided a larger variety of clinical pharmacists’ 
roles and responses. Another limitation is the low representation of pharmacists greater than forty years 
old. The majority of participants were 30-39 years of age and younger. While this is a limitation, the title 
of “clinical pharmacist” is a more recent role of a pharmacists and therefore would make the study 
population similar to real world clinical pharmacist ages. This study also did not use any major statistical 
analysis when gathering and reporting the results. It was not a major clinical study, but simply a single-
author master’s degree student research paper. If this study had more authors as well as more funding, 
results that were not solely descriptive could have been presented.  
Future Recommendations 
 When brainstorming research questions for this study, the original plan was to study a 
medication safety measure before and after a CPOE was implemented into the EHR. However, due to 
the author not being a full-time employee within the study population’s health care system, it was not 
going to be possible for her to look at patient charts within the EHR. Because of that limitation, it was 
necessary to complete research that did not involve the author using patient charts. Future studies 
could look at patient outcomes (i.g. medication safety, antimicrobial stewardship, length of stay, etc.) 
before a CPOE was implemented and compare these outcomes to after the CPOE was implemented. A 
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study looking at those outcomes could possibly provide objective measures and show nominal data for 
how CPOEs impact patient care.  
Conclusion 
 Results from this study were not meant to be robust findings that could prove statistical 
differences and change current practice. There were many obstacles that prevented the author to study 
objective measures within patient charts in the EHR. The goal of this study was to show the impact that 
HITECH has had on clinical pharmacy and the roles that clinical pharmacists’ have by creating CPOEs. The 
goal of this study was reached and hopefully, this paper provides literature for clinical pharmacy and 
CPOEs. CPOEs were a meaningful use criteria measure by CMS. Eligible professionals could receive 
monetary incentives for meeting meaningful use criteria, yet pharmacists were not eligible 
professionals. This studied showed that clinical pharmacists are knowledgeable about CPOEs, they 
believe that CPOEs reduce medication errors, and they would recommend the use of CPOEs in clinical 
and institutional settings throughout the US. Finally, it showed that clinical pharmacists assist in creating 
CPOE templates and these CPOEs involve acute pain and stoke protocols, antimicrobial stewardship, and 
insulin drips. While pharmacists were not eligibly professionals by CMS, they have still been impacted by 
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